Betamethasone (0.05% w/v) + Zinc Sulfate (0.5% w/v)

Clinical Pharmacologist's Monograph

⚠️ Prescription Only: This medicine is Schedule H/H1. Do not self-medicate.

1. Clinical Overview

A topical dermatological preparation combining a potent corticosteroid (Betamethasone) with an astringent and mild antiseptic (Zinc Sulfate). Betamethasone provides potent anti-inflammatory, anti-pruritic, and vasoconstrictive effects, while Zinc Sulfate aids in wound healing, reduces exudation, and provides a mild drying and protective effect. This combination is particularly effective for inflammatory dermatoses with exudation or mild infection risk.

OnsetDurationBioavailability
Anti-inflammatory and antipruritic effects typically begin within 1-3 hours of application.Therapeutic effects last for approximately 8-12 hours per application.Topical bioavailability is low and variable, estimated at 1-5% depending on skin integrity, site of application, and use of occlusive dressings. Systemic absorption increases with application to large areas, thin skin, or broken skin.

2. Mechanism of Action

Betamethasone binds to cytoplasmic glucocorticoid receptors, forming a complex that translocates to the nucleus. It modulates gene transcription, leading to the synthesis of anti-inflammatory proteins (lipocortin) and inhibition of pro-inflammatory mediators (cytokines, chemokines, adhesion molecules, enzymes like phospholipase A2 and COX-2). This results in potent anti-inflammatory, immunosuppressive, anti-proliferative, and vasoconstrictive effects. Zinc Sulfate provides astringent action by precipitating proteins, which reduces exudation, forms a protective layer, and has mild antiseptic properties. Zinc is also a cofactor for numerous enzymes involved in tissue repair and immune function.

3. Indications & Uses

  • Eczematous Dermatitis (Atopic, Contact, Seborrheic)
  • Psoriasis (excluding widespread plaque psoriasis)
  • Lichen Planus
  • Discoid Lupus Erythematosus
  • Neurodermatitis (Lichen Simplex Chronicus)

4. Dosage & Administration

Adult Dosage: Apply a thin film to the affected area 1-2 times daily. Frequency may be reduced to once daily or on alternate days once control is achieved. Total duration should not exceed 4 weeks continuously without medical review.

Administration: 1. Wash and dry the affected area gently. 2. Apply a thin layer and rub in lightly until it disappears. 3. Do not cover with occlusive dressings unless specifically directed by a physician. 4. Avoid contact with eyes, mouth, nostrils, and mucous membranes. 5. Wash hands after application unless hands are the treatment area.

5. Side Effects

Common side effects may include:

  • Local burning or stinging sensation (usually transient)
  • Skin dryness
  • Itching at application site
  • Erythema

6. Drug Interactions

DrugEffectSeverity
Other Topical CorticosteroidsAdditive risk of local and systemic side effects.Major
Topical Retinoids (Tretinoin, Adapalene)May increase skin irritation and dryness.Moderate
Topical Antifungals (e.g., Clotrimazole)No significant interaction; often used together for infected dermatoses.None
Oral Corticosteroids (e.g., Prednisolone)Increased risk of systemic corticosteroid effects and HPA axis suppression.Major
Live VaccinesSystemic immunosuppression may impair vaccine efficacy and increase risk of infection.Major

7. Patient Counselling

  • DO use exactly as prescribed by your doctor.
  • DO apply a thin layer only.
  • DO wash hands before and after application (unless hands are being treated).
  • DO report any lack of improvement after 1-2 weeks.
  • DON'T use on the face, groin, or armpits unless directed.
  • DON'T cover the area with tight bandages or plastic wraps unless advised.
  • DON'T use for longer than the prescribed duration.
  • DON'T share this medication with others.

8. Toxicology & Storage

Overdose: Topical: Severe local skin reactions (atrophy, striae, ulceration). Systemic (from prolonged, extensive use): Cushingoid features (moon face, central obesity), hyperglycemia, hypertension, HPA axis suppression (weakness, fatigue, hypotension), electrolyte imbalance, growth retardation in children.

Storage: Store at room temperature (15-25°C), protected from light and moisture. Do not freeze. Keep the tube tightly closed. Keep out of reach of children. Do not use after the expiry date printed on the packaging.